Absorption of ofloxacin isomers in the rat small intestine

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 10, 1997, Pages 2274-2277

  Rabbaa, Lydia ^a,b   Dautrey, Sophie ^a   Colas Linhart, Nicole ^a   Carbon, Claude ^a   Farinotti, Robert ^a,b  

^a BICHAT HOSPITAL   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; BETA LACTAM ANTIBIOTIC; CEFOPERAZONE; CIPROFLOXACIN; DICHLOROMETHANE; ENOXACIN; GLYCOPROTEIN P; OFLOXACIN; PEFLOXACIN; POTASSIUM DIHYDROGEN PHOSPHATE; QUINIDINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; VERAPAMIL;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; ENANTIOMER; INTESTINE CELL; NONHUMAN; PRIORITY JOURNAL; RACEMIC MIXTURE; RAT;

EID: 0030798778     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.10.2274     Document Type: Article

References (30)

1. Amidon, G. L., and H. J. Lee. 1994. Absorption of peptide and peptidomimetic drugs. Annu. Rev. Pharmacol. Toxicol. 34:321-341.
2. Barr, W. H., and S. Riegelman. 1970. Intestinal drug absorption and metabolism. I. Comparison of methods and models to study physiological factors of in vitro and in vivo intestinal absorption. J. Pharm. Sci. 59:154-163.
3. Barre, J., G. Houin, and P. Tillement. 1984. Dose-dependent pharmacokinetic study of pefloxacin, a new antibacterial agent, in humans. J. Pharm. Sci. 73:1379-1383.
4. Bressolle, F., F. Gonçalves, A. Gouby, and M. Galtier. 1994. Pefloxacin clinical pharmacokinetics. Clin. Pharmacokinet. 27:418-446.
5. Fujimoto, T., and S. Mitsuhashi. 1990. In vitro antibacterial activity of DR-3355, the S-(-)-isomer of ofloxacin. Chemotherapy (Tokyo) 36:268-276.
6. Furet, Y. X., J. Deshusses, and J.-C. Pechère. 1992. Transport of pefloxacin across the bacterial cytoplasmic membrane in quinolone-susceptible Staphylococcus aureus. Antimicrob. Agents Chemother. 36:2506-2511.
7. Griffith, N. M., B. H. Hirst, and N. L. Simmons. 1993. Active secretion of the fluoroquinolone ciprofloxacin by human intestinal epithelial Caco-2 cell layers. Br. J. Pharmacol. 108:575-576.
8. Griffith, N. M., B. H. Hirst, and N. L. Simmons. 1994. Active intestinal secretion of the fluoroquinolone antibacterial ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway? J. Pharmacol. Exp. Ther. 269:496-502.
9. Gruber, G., U. Jaehde, and F. Sörgel. 1988. Relationships between the chemical structure and the HPLC capacity factor of gyrase inhibitors and their metabolites in different methanol-water eluents. Fresenius Z. Anal. Chem. 330:388-389.
10. Harder, S., U. Fuhr, D. Beermann, and A. H. Staib. 1990. Ciprofloxacin absorption in different regions of the human gastrointestinal tract. Investigations with the hf-capsule. Br. J. Clin. Pharmacol. 30:35-39.
11. Hayakawa, I., S. Atarashi, S. Yokohama, M. Imamura, K.-I. Sakano, and M. Furukawa. 1986. Synthesis and antibacterial activities of optically active ofloxacin. Antimicrob. Agents Chemother. 29:163-164.
12. Hirano, T., K. Iseki, S. Miyazaki, M. Takada, M. Kobayashi, M. Sugawara, and K. Miyazaki. 1994. The stimulative effect of diffusion potential on enoxacin uptake across rat intestinal brush-border membranes. J. Pharm. Pharmacol. 46:676-679.
13. Iseki, K., T. Hirano, Y. Fukushi, Y. Kitamura, S. Miyazaki, M. Takada, M. Sugawara, H. Saitoh, and K. Miyazaki. 1992. The pH dependent uptake of enoxacin by rat intestinal brush-border membrane vesicles. J. Pharm. Pharmacol. 44:722-726.
14. Karabalut N., and G. L. Drusano. 1993. Pharmacokinetics of the quinolone antimicrobial agents, p. 195-224. In D. C. Hooper and J. S. Wolfson (ed.), Quinolone antimicrobial agents, 2nd ed. American Society for Microbiology, Washington, D.C.
15. Korten, V., and B. E. Murray. 1993. Impact of the fluoroquinolones on gastrointestinal flora. Drugs 45:125-133.
16. Le Coguic, A., R. Bidault, R. Farinotti, and A. Dauphin. 1988. Determination of ofloxacin in plasma and urine by liquid chromatography. J. Chromatogr. 434:320-323.
17. Okazaki, O., C. Kojima, H. Hakusui, and M. Nakashima. 1991. Enantioselective disposition of ofloxacin in humans. Antimicrob. Agents Chemother. 35:2106-2109.
18. Okazaki, O., T. Kurata, and H. Tachizawa. 1989. Stereoselective metabolic disposition of enantiomers of ofloxacin in rats. Xenobiotica 19:419-429.
19. Pascual, A., I. Garcia, and E. J. Perea. 1989. Fluorometric measurement of ofloxacin uptake by human polymorphonuclear leukocytes. Antimicrob. Agents Chemother. 33:653-656.
20. Ponz, F., A. Ilundain, and M. Lluch. 1980. Method for successive absorptions with intestinal perfusion in vivo. Rev. Esp. Fisiol. 35:97-104.
21. Prieto, J. G., P. Barrio, A. I. Alvarez, and G. Gomez. 1988. Kinetic mechanism for the intestinal absorption of ofloxacin. J. Pharm. Pharmacol. 40:211-212.
22. Savina, P. M., A. E. Staubus, T. S. Gaginella, and D. F. Smith. 1981. Optimal perfusion rate determined for in situ intestinal absorption studies in rats. J. Pharm. Sci. 70:239-243.
23. Shanker, L. S., D. J. Tocco, B. B. Brodie, and C. A. Hogben. 1958. Absorption of drugs from the rat small intestine. J. Pharmacol. Exp. Ther. 123:81-88.
24. Stuck, A. E., D. K. Kim, and F. J. Frey. 1992. Fleroxacin clinical pharmacokinetics. Clin. Pharmacokinet. 22:116-131.
25. Tanaka, M., T. Kurata, C. Fujisawa, Y. Ohshima, H. Aoki, O. Okazaki, and H. Hakusui. 1993. Mechanistic study of inhibition of levofloxacin absorption by aluminum hydroxide. Antimicrob. Agents Chemother. 37:2173-2178.
26. Tsuji, A., E. Miyamoto, and I. Kagami. 1978. GI absorption of β-lactam antibiotics. I. Kinetic assessment of competing absorption and degradation in GI tract. J. Pharm. Sci. 67:1701-1704.
27. Tsuji, A., E. Nakashima, I. Kagami, and T. Yamana. 1981. Intestinal absorption mechanism of amphoteric β-lactam antibiotics. I. Comparative absorption and evidence for saturable transport of amino-β-lactam antibiotics by in situ rat small intestine. J. Pharm. Sci. 70:768-775.
28. + exchanger. Clin. Pharmacol. Ther. 57:257-264.
29. Wise, R., D. Lister, C. A. M. McNully, D. Griggs, and J. M. Andrews. 1986. The comparative pharmacokinetics of five quinolones. J. Antimicrob. Chemother. 18:71-81.
30. Yamaguchi, T., M. Yukogawa, M. Sekine, and Y. Hashimoto. 1991. Intestinal absorption characteristics of sparfloxacin. Drug Metab. Dispos. 6:53-59.